Year |
Citation |
Score |
2022 |
Thomas PM, Deming MA, Sarkar A. β-Lactamase Suppression as a Strategy to Target Methicillin-Resistant : Proof of Concept. Acs Omega. 7: 46213-46221. PMID 36570253 DOI: 10.1021/acsomega.2c04381 |
0.676 |
|
2021 |
Tucker AN, Carlson TJ, Sarkar A. Challenges in Drug Discovery for Intracellular Bacteria. Pathogens (Basel, Switzerland). 10. PMID 34578204 DOI: 10.3390/pathogens10091172 |
0.714 |
|
2016 |
Sarkar A, Yu W, Desai UR, MacKerell AD, Mosier PD. Estimating glycosaminoglycan-protein interaction affinity: Water dominates the specific antithrombin-heparin interaction. Glycobiology. PMID 27496757 DOI: 10.1093/Glycob/Cww073 |
0.693 |
|
2015 |
Sarkar A, Desai UR. A Simple Method for Discovering Druggable, Specific Glycosaminoglycan-Protein Systems. Elucidation of Key Principles from Heparin/Heparan Sulfate-Binding Proteins. Plos One. 10: e0141127. PMID 26488293 DOI: 10.1371/journal.pone.0141127 |
0.558 |
|
2015 |
Boothello RS, Sarkar A, Tran VM, Nguyen TK, Sankaranarayanan NV, Mehta AY, Alabbas A, Brown S, Rossi A, Joice AC, Mencio CP, Quintero MV, Kuberan B, Desai UR. Chemoenzymatically Prepared Heparan Sulfate Containing Rare 2-O-Sulfonated Glucuronic Acid Residues. Acs Chemical Biology. 10: 1485-94. PMID 25742429 DOI: 10.1021/Acschembio.5B00071 |
0.648 |
|
2015 |
Sankaranarayanan NV, Sarkar A, Desai UR, Mosier PD. Designing "high-affinity, high-specificity" glycosaminoglycan sequences through computerized modeling. Methods in Molecular Biology (Clifton, N.J.). 1229: 289-314. PMID 25325961 DOI: 10.1007/978-1-4939-1714-3_24 |
0.707 |
|
2014 |
Argade MD, Mehta AY, Sarkar A, Desai UR. Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors. Journal of Medicinal Chemistry. 57: 3559-69. PMID 24666186 DOI: 10.1021/Jm5002698 |
0.742 |
|
2013 |
Sidhu PS, Abdel Aziz MH, Sarkar A, Mehta AY, Zhou Q, Desai UR. Designing allosteric regulators of thrombin. Exosite 2 features multiple subsites that can be targeted by sulfated small molecules for inducing inhibition. Journal of Medicinal Chemistry. 56: 5059-70. PMID 23718540 DOI: 10.1021/Jm400369Q |
0.652 |
|
2012 |
Sarkar A, Anderson KC, Kellogg GE. Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics. European Journal of Medicinal Chemistry. 52: 98-110. PMID 22483632 DOI: 10.1016/J.Ejmech.2012.03.008 |
0.552 |
|
2011 |
Farzan SF, Palermo LM, Yokoyama CC, Orefice G, Fornabaio M, Sarkar A, Kellogg GE, Greengard O, Porotto M, Moscona A. Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery Journal of Biological Chemistry. 286: 37945-37954. PMID 21799008 DOI: 10.1074/Jbc.M111.256248 |
0.528 |
|
2011 |
Spyrakis F, Cozzini P, Sarkar A, Kellogg GE. Applying induced fit in drug discovery: square pegs and round holes? Current Topics in Medicinal Chemistry. 11: 131-2. PMID 21244358 DOI: 10.2174/156802611794863553 |
0.51 |
|
2010 |
Sarkar A, Kellogg GE. Hydrophobicity--shake flasks, protein folding and drug discovery. Current Topics in Medicinal Chemistry. 10: 67-83. PMID 19929828 DOI: 10.2174/156802610790232233 |
0.563 |
|
2009 |
Li Q, Al-Ayoubi A, Guo T, Zheng H, Sarkar A, Nguyen T, Eblen ST, Grant S, Kellogg GE, Zhang S. Structure-activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: development of potential substrate-specific ERK1/2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19: 6042-6. PMID 19796943 DOI: 10.1016/J.Bmcl.2009.09.057 |
0.583 |
|
2009 |
Sarkar A, Kellogg GE. Book Review of Computational Drug Design. A Guide for Computational and Medicinal Chemists Computational Drug Design. A Guide for Computational and Medicinal Chemists . Edited by David C. Young John Wiley & Sons, Inc. , Hoboken, NJ . 2009 . xxxvi + 307 pp. 16 × 24 cm. ISBN 978-0-470-12685-1 . $100.00. Journal of Medicinal Chemistry. 52: 4977-4977. DOI: 10.1021/Jm900605K |
0.496 |
|
Show low-probability matches. |